Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22108151 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
Conditions: Hypercholesterolemia;   Metabolic Syndrome
Interventions: Drug: ezetimibe (+) simvastatin;   Drug: Comparator: atorvastatin calcium;   Drug: Comparator:  Placebo (unspecified)

Indicates status has not been verified in more than two years